Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 9, 2023

Rhea-AI Summary

Orthofix Medical Inc. (NASDAQ:OFIX) will release its first quarter 2023 financial results on May 9, 2023, after market close. A conference call to discuss these results will take place at 4:30 p.m. ET on the same day, with access details available for interested parties. The newly merged Orthofix-SeaSpine organization is recognized as a leader in the global spine and orthopedics sector, offering a diverse range of products distributed across approximately 68 countries. The company is headquartered in Lewisville, Texas, and maintains a focus on innovation in spine and biologics products, with significant presence across multiple locations including California and Europe.

Positive

• Upcoming release of Q1 2023 financial results on May 9, 2023.
• Strong global presence with products distributed in approximately 68 countries.
• Merged entity expected to enhance product offerings in spine and orthopedics.

Negative

• None.

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2023 financial results on Tuesday, May 9, 2023 after market close. The company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.

Interested parties may access the conference call by dialing (888) 330-2508 in the U.S., and (240) 789-2735 in all other locations, and referencing the event passcode 9556380. A replay of the call will be available for three weeks by dialing (800) 770-2030 in the U.S., and (647) 362-9199 in all other locations, and entering the event passcode 9556380. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com.

About the Combined Company:

The newly merged Orthofix-SeaSpine organization is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.

The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and Sao Paulo, Brazil.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230426005260/en/

Alexa Huerta

Investor Relations

Tel 214 937 3190

alexahuerta@orthofix.com

Denise Landry

Media Relations

Tel 214 937 2529

deniselandry@orthofix.com

Source: Orthofix Medical Inc.

FAQ

When will Orthofix release its Q1 2023 financial results?

Orthofix will release its Q1 2023 financial results on May 9, 2023, after market close.

What time is the conference call for Orthofix's Q1 2023 financial results?

The conference call for Orthofix's Q1 2023 financial results will be at 4:30 p.m. ET on May 9, 2023.

How can I access the conference call for Orthofix's financial results?

You can access the conference call by dialing (888) 330-2508 in the U.S. or (240) 789-2735 internationally, and using the event passcode 9556380.

What is the significance of the merger between Orthofix and SeaSpine?

The merger creates a leader in the spine and orthopedics market, broadening the product portfolio and enhancing global reach.